Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Current Taxes for 2 consecutive years, with $320000.0 as the latest value for Q2 2022.

  • Quarterly Current Taxes changed N/A to $320000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $320000.0 through Jun 2022, changed N/A year-over-year, with the annual reading at $601000.0 for FY2021, N/A changed from the prior year.
  • Current Taxes for Q2 2022 was $320000.0 at Cartesian Therapeutics, roughly flat from $320000.0 in the prior quarter.
  • The five-year high for Current Taxes was $15.8 million in Q3 2021, with the low at $320000.0 in Q1 2022.